{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T05:23:00Z","timestamp":1793856180545,"version":"4.6.1"},"reference-count":54,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Minoxidil, in addition to its vasodilatory effect, has also immunomodulatory properties that may be partially responsible for its efficacy in alopecia areata. The aim of the study was to evaluate the efficacy of monotherapy with topical or oral minoxidil in alopecia areata. Methods: A systematic review and meta-analysis of the efficacy of monotherapy with minoxidil in alopecia areata was conducted following the PRISMA guidelines. Efficacy of minoxidil in alopecia areata was evaluated separately for three groups of the patients: (1) treated with 5% topical minoxidil, (2) less than 5% topical minoxidil, and (3) oral minoxidil. Therapeutic response was defined as any regrowth of terminal hair. Results: Of 244 articles, 13 were considered eligible for the further analysis. The study included 372 patients with alopecia areata (338 using topical minoxidil and 34 taking oral minoxidil). The mean time of treatment ranged from 2 to 60 weeks (mean: 27 weeks). The response rate for 5% topical was 82% (95% CI 0.7\u20130.93) and 58% (95% Cl 0.5\u20130.67) for the less than 5% topical minoxidil group. For the group of patients treated orally, the response rate was 82%. Conclusions: Minoxidil, both topical and oral, may be beneficial in monotherapy in patients with alopecia areata. 5% topical minoxidil is characterized by significantly higher efficacy compared to minoxidil at a lower concentration. There are no sufficient data to recommend minoxidil as a first-line therapeutic option for alopecia areata.<\/jats:p>","DOI":"10.3390\/jcm13247712","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T10:54:02Z","timestamp":1734432842000},"page":"7712","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4120-6745","authenticated-orcid":false,"given":"Micha\u0142","family":"Majewski","sequence":"first","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, Nowogrodzka 59 Str., 02-014 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Garda\u015b","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, Nowogrodzka 59 Str., 02-014 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-3589","authenticated-orcid":false,"given":"Anna","family":"Wa\u015bkiel-Burnat","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, Nowogrodzka 59 Str., 02-014 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5652-4397","authenticated-orcid":false,"given":"Micha\u0142","family":"Ordak","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy and Pharmaceutical Care, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Str., 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8308-1023","authenticated-orcid":false,"given":"Lidia","family":"Rudnicka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, Nowogrodzka 59 Str., 02-014 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jdermsci.2023.09.008","article-title":"Alopecia areata: What\u2019s new in the epidemiology, comorbidities, and pathogenesis?","volume":"112","author":"Dainichi","year":"2023","journal-title":"J. Dermatol. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","article-title":"Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis","volume":"82","author":"Lee","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17011","DOI":"10.1038\/nrdp.2017.11","article-title":"Alopecia areata","volume":"3","author":"Pratt","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12016-021-08883-0","article-title":"Alopecia Areata: An Update on Etiopathogenesis, Diagnosis, and Management","volume":"61","author":"Zhou","year":"2021","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2018.12.001","article-title":"Alopecia areata: A multifactorial autoimmune condition","volume":"98","author":"Simakou","year":"2019","journal-title":"J. Autoimmun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5114\/ceji.2020.101264","article-title":"Immunology of alopecia areata","volume":"45","author":"Rudnicka","year":"2020","journal-title":"Cent. Eur. J. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.autrev.2005.07.001","article-title":"Alopecia areata: A tissue specific autoimmune disease of the hair follicle","volume":"5","author":"Gilhar","year":"2006","journal-title":"Autoimmun Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/1523-1747.ep12375477","article-title":"Antibodies to hair follicles in alopecia areata","volume":"102","author":"Tobin","year":"1994","journal-title":"J. Investig. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/exd.14129","article-title":"Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata","volume":"29","author":"Ito","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/jdv.17187","article-title":"Therapeutic management in paediatric alopecia areata: A systematic review","volume":"35","author":"Sikora","year":"2021","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1080\/09546634.2021.1945527","article-title":"Minoxidil: A comprehensive review","volume":"33","author":"Gupta","year":"2022","journal-title":"J. Dermatolog. Treat."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s40272-017-0239-z","article-title":"Alopecia Areata: An Update on Treatment Options for Children","volume":"19","author":"Peloquin","year":"2017","journal-title":"Paediatr. Drugs"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e12437","DOI":"10.1111\/dth.12437","article-title":"Platelets rich plasma vs. minoxidil 5% in treatment of alopecia areata: A trichoscopic evaluation","volume":"30","author":"Ibrahim","year":"2017","journal-title":"Dermatol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e15943","DOI":"10.1111\/dth.15943","article-title":"Comparison of efficacy, safety and satisfaction of latanoprost vs. minoxidil, betamethasone and in combination in patients with alopecia areata: A blinded multiple group randomized controlled trial","volume":"35","author":"Ghassemi","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/09546634.2017.1330527","article-title":"Efficacy of topical latanoprost vs. minoxidil and betamethasone valerate on the treatment of alopecia areata","volume":"29","year":"2018","journal-title":"J. Dermatolog. Treat."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e15696","DOI":"10.1111\/dth.15696","article-title":"Comparative study between topical methotrexate 1% gel and minoxidil 5% gel in the treatment of localized alopecia areata","volume":"35","author":"Toma","year":"2022","journal-title":"Dermatol. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0190-9622(87)70096-6","article-title":"Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy","volume":"16","author":"Price","year":"1987","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/1523-1747.ep12611409","article-title":"Topical minoxidil in alopecia areata: No effect on the perifollicular lymphoid infiltration","volume":"99","author":"Khoury","year":"1992","journal-title":"J. Investig. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/archderm.1986.01660140070020","article-title":"Topical minoxidil dose-response effect in alopecia areata","volume":"122","author":"West","year":"1986","journal-title":"Arch. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000248901","article-title":"Topical minoxidil in extensive alopecia areata, including 3-year follow-up","volume":"175","author":"Price","year":"1987","journal-title":"Dermatologica"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0190-9622(87)80003-8","article-title":"Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata","volume":"16","year":"1987","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3949\/ccjm.56.2.149","article-title":"Extensive alopecia areata. Results of treatment with 3% topical minoxidil","volume":"56","author":"Ranchoff","year":"1989","journal-title":"Clevel. Clin. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.288.6419.794-a","article-title":"Topical minoxidil in the treatment of alopecia areata","volume":"288","author":"Maitland","year":"1984","journal-title":"Br. Med. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2340\/0001555565172175","article-title":"Topical minoxidil for extended areate alopecia","volume":"65","author":"Frentz","year":"1985","journal-title":"Acta Derm. Venereol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000248899","article-title":"Immunohistochemical characterization of the cellular infiltrate in severe alopecia areata before and after minoxidil treatment","volume":"175","author":"Fiedler","year":"1987","journal-title":"Dermatologica"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5114\/dr.2022.126603","article-title":"The use of minoxidil in diseases associated with hair loss","volume":"109","author":"Graczyk","year":"2022","journal-title":"Dermatol. Rev.\/Przegl\u0105d Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1096\/fj.07-099424","article-title":"Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil","volume":"22","author":"Shorter","year":"2008","journal-title":"FASEB J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","article-title":"Minoxidil: Mechanisms of action on hair growth","volume":"150","author":"Messenger","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/187221312800166859","article-title":"Minoxidil use in dermatology, side effects and recent patents","volume":"6","author":"Rossi","year":"2012","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0006-2952(88)90174-8","article-title":"Selective inhibition by minoxidil of prostacyclin production by cells in culture","volume":"37","author":"Kvedar","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jdermsci.2010.02.011","article-title":"Identification of transcriptional targets of Wnt\/beta-catenin signaling in dermal papilla cells of human scalp hair follicles: EP2 is a novel transcriptional target of Wnt3a","volume":"58","author":"Shin","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2020.06.1009","article-title":"Oral minoxidil treatment for hair loss: A review of efficacy and safety","volume":"84","author":"Randolph","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0008-6363(00)00268-6","article-title":"Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family","volume":"49","author":"Zachary","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1172\/JCI11317","article-title":"Control of hair growth and follicle size by VEGF-mediated angiogenesis","volume":"107","author":"Yano","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Wang, Q., Zhou, M., Zhang, H., Hou, Z., and Liu, D. (2023). Hypoxia Treatment of Adipose Mesenchymal Stem Cells Promotes the Growth of Dermal Papilla Cells via HIF-1\u03b1 and ERK1\/2 Signaling Pathways. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241311198"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0738-081X(88)90079-X","article-title":"Direct T-cell effects of minoxidil","volume":"6","author":"Fiedler","year":"1988","journal-title":"Clin. Dermatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-4362.1985.tb05774.x","article-title":"In vitro suppression of human lymphocyte activity by minoxidil","volume":"24","author":"Galbraith","year":"1985","journal-title":"Int. J. Dermatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0190-9622(87)70083-8","article-title":"Potential mechanisms of minoxidil-induced hair growth in alopecia areata","volume":"16","year":"1987","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0190-9622(93)70238-O","article-title":"Treatment of chronic severe alopecia areata with topical diphenylcyclopropenone and 5% minoxidil: A clinical and immunopathologic evaluation","volume":"29","author":"Shapiro","year":"1993","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2133.1987.tb07357.x","article-title":"Response to minoxidil in severe alopecia areata correlates with T lymphocyte stimulation","volume":"117","author":"Buys","year":"1987","journal-title":"Br. J. Dermatol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jdermsci.2004.01.002","article-title":"Effect of minoxidil on proliferation and apoptosis in dermal papilla cells of human hair follicle","volume":"34","author":"Han","year":"2004","journal-title":"J. Dermatol. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/ijt.ijt_18_17","article-title":"Minoxidil Downregulates Interleukin-1 Alpha Gene Expression in HaCaT Cells","volume":"10","author":"Pekmezci","year":"2018","journal-title":"Int. J. Trichology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1346-8138.16207","article-title":"Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines","volume":"49","author":"Fukuyama","year":"2022","journal-title":"J. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/1523-1747.ep12277095","article-title":"Minoxidil stimulates mouse vibrissae follicles in organ culture","volume":"92","author":"Buhl","year":"1989","journal-title":"J. Investig. Dermatol."},{"key":"ref_46","first-page":"937","article-title":"The effect of topical minoxidil treatment on follicular sulfotransferase enzymatic activity","volume":"32","author":"Goren","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/jdv.19768","article-title":"European expert consensus statement on the systemic treatment of alopecia areata","volume":"38","author":"Rudnicka","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jaad.2019.08.080","article-title":"Combination tofacitinib and oral minoxidil treatment for severe alopecia areata","volume":"85","author":"Wambier","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s10103-023-03734-0","article-title":"Laser and light therapy combined with topical minoxidil for alopecia areata: A systematic review and meta-analysis of randomized controlled trials","volume":"38","author":"Zhang","year":"2023","journal-title":"Lasers Med. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/archderm.1990.01670300056006","article-title":"Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin","volume":"126","author":"Fiedler","year":"1990","journal-title":"Arch. Dermatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1067\/mjd.2002.124088","article-title":"A randomized clinical trial of 5% topical minoxidil vs. 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/jdv.19964","article-title":"A ranking of treatment efficacy in alopecia areata is not possible without head-to-head studies","volume":"38","author":"Rudnicka","year":"2024","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10238-020-00673-w","article-title":"Alopecia areata: A review on diagnosis, immunological etiopathogenesis and treatment options","volume":"21","author":"Sterkens","year":"2021","journal-title":"Clin. Exp. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2007.04.012","article-title":"A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men","volume":"57","author":"Olsen","year":"2007","journal-title":"J. Am. Acad. Dermatol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7712\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:54:09Z","timestamp":1760115249000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/24\/7712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":54,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["jcm13247712"],"URL":"https:\/\/doi.org\/10.3390\/jcm13247712","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}